These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Price type key:
Federal Supply Schedule (FSS): generally available to all Federal Govt agencies /
'BIG4' prices: VA, DoD, Public Health & Coast Guard only /
National Contracts (NC): Available to specific agencies
00904-7495 Market Analysis and Financial Projection
Omega-3 Acid Ethyl Esters (NDC 00904-7495), manufactured by Major Pharmaceuticals, is a prescription medication primarily used to manage high triglyceride levels and support cardiovascular health. Below is a detailed analysis of its market dynamics and price projections:
Market Overview
The global omega-3 prescription drugs market, which includes omega-3 ethyl esters, was valued at $1.35 billion in 2024 and is projected to grow at a CAGR of 4.90%, reaching $1.80 billion by 2030[6]. For NDC 00904-7495 specifically, growth is driven by:
Cardiovascular health demand: Rising global prevalence of heart diseases and hypertriglyceridemia[6][8].
Aging populations: Increased susceptibility to chronic conditions, with ~727 million people aged 65+ globally in 2020[6][8].
Functional food trends: Consumer preference for supplements integrated into daily diets[6].
Regional Market Insights
North America dominates the market, accounting for the largest revenue share due to high obesity rates and cardiovascular disease prevalence. The U.S. leads demand, with Omega-3-Acid Ethyl Esters widely prescribed[6][10].
Europe follows, driven by preventive healthcare adoption and regulatory support for biosimilars[6][10].
Asia-Pacific shows the fastest growth (CAGR ~7.1%), fueled by improving healthcare infrastructure and rising middle-class health awareness[10].
Price Analysis
Current Pricing (2024–2025)
A 20-capsule pack (1,000 mg) costs $21.57–$22, averaging $0.48–$1.08 per capsule depending on quantity purchased[7].
Bulk purchases (500 capsules) reduce per-unit costs to $0.62[7].
Future Price Projections (2025–2030)
Stabilization/Moderate Decline: Economies of scale and production efficiencies may lower costs slightly[6].
Volatility Risks:
Raw material scarcity: Fish oil supply disruptions (e.g., El Niño impacting Peruvian anchovy catches) could spike prices[11].
Regulatory compliance: Stricter purity standards (e.g., European Pharmacopoeia) may raise production costs by 8–12%[11].
Competition: Algae-based omega-3 alternatives capturing ~12% of the U.S. market could pressure traditional suppliers[11].
Key Market Drivers vs. Challenges
Drivers
Challenges
Aging demographics[6][8]
High raw material costs[11]
Rising cardiovascular disease rates[6]
Environmental concerns (overfishing)[8]
Expansion into functional foods[6]
Currency and trade policy fluctuations[11]
Strategic Opportunities
Product Innovation: Enhanced formulations for better bioavailability or combined nutrient profiles[6][8].
Sustainable Sourcing: Algae-based omega-3 production to reduce reliance on fish oil[6][11].
Emerging Markets: Targeting regions like Latin America and Asia-Pacific with preventive health campaigns[6][10].
Conclusion
NDC 00904-7495 is positioned for steady growth, driven by cardiovascular health trends and aging populations. While prices are expected to stabilize through production scaling, external factors like supply chain disruptions and regulatory shifts may introduce short-term volatility. Strategic investments in sustainability and market expansion will be critical for long-term success.
Highlight: "Omega-3 ethyl esters reduce triglycerides by 20–50% in patients with severe hypertriglyceridemia, underscoring their clinical importance"[6].
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
